Synonyms: Ro-109359 | Tegison®
etretinate is an approved drug (FDA (1986))
Compound class:
Synthetic organic
Comment: Etretinate is a highly lipophilic second-generation retinoid. Its use has largely been discontinued as it was discovered to be a long-acting teratogen, with detectable levels in plasma up to three years post-therapy.
View more information in the IUPHAR Pharmacology Education Project: etretinate |
|
No information available. |
Summary of Clinical Use |
Etretinate was used to treat severe psoriasis. The drug was removed from the Canadian and US markets due to the high risk of birth defects associated with its use. Etretinate has been replaced by acitretin, a safer metabolite with a much reduced half-life. The brand name Tigason appears to be in use in Japan. |